Biocorrx (OTCMKTS:BICX) Announces Quarterly Earnings Results

Biocorrx (OTCMKTS:BICX) posted its quarterly earnings data on Friday. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02, Zacks reports. The business had revenue of $0.09 million during the quarter, compared to analyst estimates of $0.24 million.

Biocorrx Stock Down 45.7%

Shares of OTCMKTS BICX opened at $0.15 on Friday. The stock has a market capitalization of $4.52 million, a PE ratio of -1.27 and a beta of 0.19. The firm has a fifty day moving average of $0.32 and a 200-day moving average of $0.35. Biocorrx has a 52-week low of $0.15 and a 52-week high of $1.28.

Biocorrx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.